Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo

BACKGROUND: The tyrosine kinase receptor HER4 is a member of the epidermal growth factor receptor (EGFR) family. It plays diverse roles in cancer development and cancer progression and can both exert oncogenic and tumour-suppressive activities. Alternatively spliced isoforms of HER4 are critical to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nielsen, T O, Sorensen, S, Dagnæs-Hansen, F, Kjems, J, Sorensen, B S
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2013
Gaiak:
Translational Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3681029/
https://ncbi.nlm.nih.gov/pubmed/23695025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.247
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak